ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24 | -99.9% | 3,800 | -1.9% | 0.00% | – |
Q3 2022 | $31,000 | +29.2% | 3,874 | +1.9% | 0.00% | – |
Q2 2022 | $24,000 | +33.3% | 3,800 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | +260.0% | 3,800 | +838.3% | 0.00% | – |
Q3 2021 | $5,000 | -44.4% | 405 | 0.0% | 0.00% | – |
Q2 2021 | $9,000 | -86.6% | 405 | -83.2% | 0.00% | – |
Q1 2021 | $67,000 | +6.3% | 2,405 | 0.0% | 0.00% | – |
Q4 2020 | $63,000 | +600.0% | 2,405 | +843.1% | 0.00% | – |
Q3 2020 | $9,000 | -30.8% | 255 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +116.7% | 255 | +27.5% | 0.00% | – |
Q1 2020 | $6,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q4 2019 | $12,000 | +71.4% | 200 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | +16.7% | 200 | +53.8% | 0.00% | – |
Q2 2019 | $6,000 | +20.0% | 130 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | -16.7% | 130 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | 0.0% | 130 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -40.0% | 130 | -50.0% | 0.00% | – |
Q2 2018 | $10,000 | -9.1% | 260 | +73.3% | 0.00% | – |
Q1 2018 | $11,000 | -31.2% | 150 | -40.0% | 0.00% | – |
Q4 2017 | $16,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |